Pub Date : 2025-07-01Epub Date: 2025-09-30DOI: 10.12865/CHSJ.51.03.14
Ahu Yorulmaz
Palmoplantar pustulosis (PPP) is a chronic, recurrent inflammatory dermatosis affecting the palms and soles, classified as a form of acral pustular psoriasis. Nail involvement occurs in over half of PPP patients. This report presents a patient with PPP and idiopathic thrombocytopenic purpura who exhibited purpuric plantar and nail lesions. Dermoscopic examination revealed the hypopyon sign in both plantar and nail lesions, as well as centrally located eccrine duct openings within the plantar pustules. The hypopyon sign has been rarely documented, with previous reports limited to lymphangioma circumscriptum and angiosarcoma. This case supports the role of microvascular abnormalities in psoriasis pathogenesis and warrants further investigation into the underlying mechanisms.
{"title":"Hypopyon Sign in Acral Lesions: Dermoscopic Findings of a Patient with Palmoplantar Pustulosis.","authors":"Ahu Yorulmaz","doi":"10.12865/CHSJ.51.03.14","DOIUrl":"10.12865/CHSJ.51.03.14","url":null,"abstract":"<p><p>Palmoplantar pustulosis (PPP) is a chronic, recurrent inflammatory dermatosis affecting the palms and soles, classified as a form of acral pustular psoriasis. Nail involvement occurs in over half of PPP patients. This report presents a patient with PPP and idiopathic thrombocytopenic purpura who exhibited purpuric plantar and nail lesions. Dermoscopic examination revealed the hypopyon sign in both plantar and nail lesions, as well as centrally located eccrine duct openings within the plantar pustules. The hypopyon sign has been rarely documented, with previous reports limited to lymphangioma circumscriptum and angiosarcoma. This case supports the role of microvascular abnormalities in psoriasis pathogenesis and warrants further investigation into the underlying mechanisms.</p>","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":"51 3","pages":"416-419"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12831544/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146055655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01Epub Date: 2025-09-30DOI: 10.12865/CHSJ.51.03.09
Mihai-Alexandru Radu, Andrei Pănuș, Andrei Drocaș, Dragoș Florin Vasile, Nicoleta Alice Drăgoescu, George Mitroi, Cecil Sorin Mirea, Petru Octavian Drăgoescu
Prostate cancer is the most common malignancy in men, and systematic ultrasound-guided biopsy remains the diagnostic gold standard. The transrectal (TR) route, while widely used, carries an increased risk of infectious and haemorrhagic complications. The transperineal (TP) biopsy approach has been developed to reduce these risks while maintaining comparable diagnostic accuracy. This study aimed to compare cancer detection rates, histopathological patterns, and complication rates between TP and TR prostate biopsies.
Methods: A retrospective analysis was conducted on 310 patients who underwent prostate biopsy between January 2023 and January 2024. Patients were divided into TP (n=178) and TR (n=132) groups. Clinically significant prostate cancer (csPCa) was defined as Gleason score ≥7 or ISUP grade ≥2. Data regarding detection rates, ISUP distribution, complications, and age were compared using the Chi-square test. Age distribution and ISUP grade across age decades were evaluated to exclude age-related bias.
Results: The overall cancer detection rate was significantly higher in the TP group (60.67%) than in the TR group (49.24%) (p=0.045), while csPCa detection did not differ significantly (TP 49.44% vs TR 43.94%, p=0.20). High-grade (ISUP 5) tumours were more frequent in the TR group (41.5% vs 25.0%, p=0.034). Complications were significantly more common after TR biopsy (15.2% vs 6.7%, p=0.027), with infections and rectal bleeding occurring only in TR cases. Patient age distribution was similar between groups (χ²=4.49, p=0.213), and ISUP grade distribution by age decade showed no significant differences (all p>0.05). No non-prostatic pathology was identified in either cohort.
Conclusions: Transperineal prostate biopsy demonstrated a higher overall detection rate and significantly fewer complications compared to the transrectal approach, while maintaining equivalent detection of clinically significant prostate cancer. The absence of age-related or histological bias confirms that the lower complication rate of TP biopsy is attributable to the procedural route rather than patient-related factors.
前列腺癌是男性最常见的恶性肿瘤,系统的超声引导活检仍然是诊断的金标准。经直肠(TR)途径虽然被广泛使用,但感染和出血性并发症的风险增加。经会阴(TP)活检方法的发展是为了降低这些风险,同时保持相当的诊断准确性。本研究旨在比较TP和TR前列腺活检的癌症检出率、组织病理学模式和并发症发生率。方法:对2023年1月至2024年1月接受前列腺活检的310例患者进行回顾性分析。患者分为TP组(n=178)和TR组(n=132)。临床上显著性前列腺癌(csPCa)定义为Gleason评分≥7或ISUP分级≥2。采用卡方检验比较检出率、ISUP分布、并发症和年龄等数据。评估年龄分布和ISUP分级以排除年龄相关偏倚。结果:TP组总癌检出率(60.67%)显著高于TR组(49.24%)(p=0.045),而csPCa检出率差异无统计学意义(TP 49.44% vs TR 43.94%, p=0.20)。高级别(ISUP 5)肿瘤在TR组更常见(41.5% vs 25.0%, p=0.034)。TR活检后并发症更为常见(15.2% vs 6.7%, p=0.027),感染和直肠出血仅发生在TR病例中。两组患者年龄分布相似(χ²=4.49,p=0.213), ISUP分级按年龄划分无显著差异(p < 0.05)。两组患者均未发现非前列腺病变。结论:与经直肠入路相比,经会阴前列腺活检总体检出率更高,并发症明显减少,同时对临床意义重大的前列腺癌保持相当的检出率。没有年龄相关或组织学偏差,证实TP活检的并发症发生率较低是由于手术途径而不是患者相关因素。
{"title":"Transperineal versus Transrectal Prostate Biopsy: Comparative Analysis of Cancer Detection and Complication Rates.","authors":"Mihai-Alexandru Radu, Andrei Pănuș, Andrei Drocaș, Dragoș Florin Vasile, Nicoleta Alice Drăgoescu, George Mitroi, Cecil Sorin Mirea, Petru Octavian Drăgoescu","doi":"10.12865/CHSJ.51.03.09","DOIUrl":"10.12865/CHSJ.51.03.09","url":null,"abstract":"<p><p>Prostate cancer is the most common malignancy in men, and systematic ultrasound-guided biopsy remains the diagnostic gold standard. The transrectal (TR) route, while widely used, carries an increased risk of infectious and haemorrhagic complications. The transperineal (TP) biopsy approach has been developed to reduce these risks while maintaining comparable diagnostic accuracy. This study aimed to compare cancer detection rates, histopathological patterns, and complication rates between TP and TR prostate biopsies.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on 310 patients who underwent prostate biopsy between January 2023 and January 2024. Patients were divided into TP (n=178) and TR (n=132) groups. Clinically significant prostate cancer (csPCa) was defined as Gleason score ≥7 or ISUP grade ≥2. Data regarding detection rates, ISUP distribution, complications, and age were compared using the Chi-square test. Age distribution and ISUP grade across age decades were evaluated to exclude age-related bias.</p><p><strong>Results: </strong>The overall cancer detection rate was significantly higher in the TP group (60.67%) than in the TR group (49.24%) (p=0.045), while csPCa detection did not differ significantly (TP 49.44% vs TR 43.94%, p=0.20). High-grade (ISUP 5) tumours were more frequent in the TR group (41.5% vs 25.0%, p=0.034). Complications were significantly more common after TR biopsy (15.2% vs 6.7%, p=0.027), with infections and rectal bleeding occurring only in TR cases. Patient age distribution was similar between groups (χ²=4.49, p=0.213), and ISUP grade distribution by age decade showed no significant differences (all p>0.05). No non-prostatic pathology was identified in either cohort.</p><p><strong>Conclusions: </strong>Transperineal prostate biopsy demonstrated a higher overall detection rate and significantly fewer complications compared to the transrectal approach, while maintaining equivalent detection of clinically significant prostate cancer. The absence of age-related or histological bias confirms that the lower complication rate of TP biopsy is attributable to the procedural route rather than patient-related factors.</p>","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":"51 3","pages":"376-382"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12831550/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146055737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01Epub Date: 2025-09-30DOI: 10.12865/CHSJ.51.03.13
Antonio Andrusca, Cristina Maria Mihai, Adriana Luminita Balasa, Larisia Mihai, Claudia Simona Cambrea, Irina Ion, Emil Anton, Tatiana Chisnoiu, Ramona Mihaela Stoicescu, Ileana Ion
Antibiotic-resistant infections in children are a growing clinical concern worldwide. Klebsiella pneumoniae (K.pneumoniae) is a leading cause of hospital-acquired infections and often exhibits multidrug resistance, including extended-spectrum β-lactamase (ESBL) production and carbapenem resistance. This study examines the prevalence of K. pneumoniae in pediatric patients upon hospital admission and characterizes its antibiotic resistance profile.
Objectives: This study aimed to determine its prevalence and resistance patterns in children at hospital admission.
Methods: We conducted a retrospective study of 93 pediatric inpatients admitted to a tertiary children's hospital. Clinical and microbiology records were reviewed to identify patients with K. pneumoniae isolated from admission cultures. Antibiotic susceptibility testing was performed on each K. pneumoniae isolate for a panel of antibiotics spanning penicillins, cephalosporins, carbapenems, aminoglycosides, tetracyclines, and fluoroquinolones. The frequencies of resistance and sensitivity were determined for each antibiotic. Fisher's exact tests and factorial ANOVA were used to assess associations between patient diagnosis and resistance.
Results: Out of 93 pediatric patients, 18 (19.35%) had K. pneumoniae isolated, with 72.2% of strains classified as multidrug-resistant. Resistance was highest to ceftriaxone (50%) and ampicillin (44%). Carbapenems and amikacin remained largely effective.
Conclusion: Nearly one-fifth of children admitted had K. pneumoniae detected on initial cultures, with a majority of these isolates exhibiting multidrug resistance, especially to common cephalosporins and penicillins. The high rate of ceftriaxone resistance suggests a prevalence of ESBL-producing strains. Carbapenems and amikacin remained largely effective, underscoring their importance as empiric or targeted therapies in severe pediatric infections.
{"title":"High Prevalence of Multidrug- Resistant Klebsiella Pneumoniae in Pediatric Patients: A Retrospective Analysis.","authors":"Antonio Andrusca, Cristina Maria Mihai, Adriana Luminita Balasa, Larisia Mihai, Claudia Simona Cambrea, Irina Ion, Emil Anton, Tatiana Chisnoiu, Ramona Mihaela Stoicescu, Ileana Ion","doi":"10.12865/CHSJ.51.03.13","DOIUrl":"10.12865/CHSJ.51.03.13","url":null,"abstract":"<p><p>Antibiotic-resistant infections in children are a growing clinical concern worldwide. Klebsiella pneumoniae (K.pneumoniae) is a leading cause of hospital-acquired infections and often exhibits multidrug resistance, including extended-spectrum β-lactamase (ESBL) production and carbapenem resistance. This study examines the prevalence of K. pneumoniae in pediatric patients upon hospital admission and characterizes its antibiotic resistance profile.</p><p><strong>Objectives: </strong>This study aimed to determine its prevalence and resistance patterns in children at hospital admission.</p><p><strong>Methods: </strong>We conducted a retrospective study of 93 pediatric inpatients admitted to a tertiary children's hospital. Clinical and microbiology records were reviewed to identify patients with K. pneumoniae isolated from admission cultures. Antibiotic susceptibility testing was performed on each K. pneumoniae isolate for a panel of antibiotics spanning penicillins, cephalosporins, carbapenems, aminoglycosides, tetracyclines, and fluoroquinolones. The frequencies of resistance and sensitivity were determined for each antibiotic. Fisher's exact tests and factorial ANOVA were used to assess associations between patient diagnosis and resistance.</p><p><strong>Results: </strong>Out of 93 pediatric patients, 18 (19.35%) had K. pneumoniae isolated, with 72.2% of strains classified as multidrug-resistant. Resistance was highest to ceftriaxone (50%) and ampicillin (44%). Carbapenems and amikacin remained largely effective.</p><p><strong>Conclusion: </strong>Nearly one-fifth of children admitted had K. pneumoniae detected on initial cultures, with a majority of these isolates exhibiting multidrug resistance, especially to common cephalosporins and penicillins. The high rate of ceftriaxone resistance suggests a prevalence of ESBL-producing strains. Carbapenems and amikacin remained largely effective, underscoring their importance as empiric or targeted therapies in severe pediatric infections.</p>","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":"51 3","pages":"407-415"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12831549/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146046963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01Epub Date: 2025-09-30DOI: 10.12865/CHSJ.51.03.06
Luana Rossato Dias, Paulo Moacir Mesquita Filho, Bruno Missio Gregol
Patients with severe traumatic brain injury (TBI) develop systemic clinical repercussions, mainly respiratory, with tracheostomy being one of the necessary interventions. This procedure offers benefits such as greater comfort and mobility, as well as, according to some studies, early weaning from mechanical ventilation.
Objective: To evaluate the benefits and the ideal timing for performing tracheostomy in patients with severe TBI, determining its importance in clinical evolution, and to quantify associated complications, as well as the context of brain injury and its systemic repercussions.
Methods: Retrospective observational study that evaluated, through patient medical records, the outcomes of patients with severe TBI at the Hospital de Clínicas de Passo Fundo between January 2016 and December 2018.
Results: Patients who underwent early tracheostomy used antibiotics for an average of 18.5 days compared to 30.3 days for late tracheostomy. Regarding length of stay in the Intensive Care Unit, the early tracheostomy group remained an average of 14.4 days versus 16.7 days for the late tracheostomy group. For total hospital stay, the early tracheostomy group stayed an average of 25.9 days compared to 40.5 days for late tracheostomy. No significant difference in mortality was observed between the two groups.
Conclusion: Early tracheostomy should be instituted in patients with severe TBI with the aim of improving their clinical outcomes.
严重创伤性脑损伤(TBI)患者会出现以呼吸系统为主的系统性临床反应,气管切开术是必要的干预措施之一。根据一些研究,这一程序提供了诸如更大的舒适性和灵活性等好处,并且可以早期脱离机械通气。目的:评估严重TBI患者气管切开术的益处和理想时机,确定其在临床发展中的重要性,量化相关并发症,以及脑损伤的背景及其全身影响。方法:回顾性观察研究,通过患者医疗记录评估2016年1月至2018年12月期间在Clínicas de Passo Fundo医院治疗的严重TBI患者的预后。结果:早期气管切开术患者平均使用抗生素18.5天,而晚期气管切开术患者平均使用抗生素30.3天。在重症监护室的住院时间方面,早期气管切开术组的平均住院时间为14.4天,而晚期气管切开术组的平均住院时间为16.7天。就总住院时间而言,早期气管切开术组平均住院时间为25.9天,而晚期气管切开术组平均住院时间为40.5天。两组间死亡率无显著差异。结论:重型脑外伤患者应及早行气管切开术,以提高临床疗效。
{"title":"Outcome of Patients with Severe Traumatic Brain Injury: Tracheostomy and Associated Complications.","authors":"Luana Rossato Dias, Paulo Moacir Mesquita Filho, Bruno Missio Gregol","doi":"10.12865/CHSJ.51.03.06","DOIUrl":"10.12865/CHSJ.51.03.06","url":null,"abstract":"<p><p>Patients with severe traumatic brain injury (TBI) develop systemic clinical repercussions, mainly respiratory, with tracheostomy being one of the necessary interventions. This procedure offers benefits such as greater comfort and mobility, as well as, according to some studies, early weaning from mechanical ventilation.</p><p><strong>Objective: </strong>To evaluate the benefits and the ideal timing for performing tracheostomy in patients with severe TBI, determining its importance in clinical evolution, and to quantify associated complications, as well as the context of brain injury and its systemic repercussions.</p><p><strong>Methods: </strong>Retrospective observational study that evaluated, through patient medical records, the outcomes of patients with severe TBI at the Hospital de Clínicas de Passo Fundo between January 2016 and December 2018.</p><p><strong>Results: </strong>Patients who underwent early tracheostomy used antibiotics for an average of 18.5 days compared to 30.3 days for late tracheostomy. Regarding length of stay in the Intensive Care Unit, the early tracheostomy group remained an average of 14.4 days versus 16.7 days for the late tracheostomy group. For total hospital stay, the early tracheostomy group stayed an average of 25.9 days compared to 40.5 days for late tracheostomy. No significant difference in mortality was observed between the two groups.</p><p><strong>Conclusion: </strong>Early tracheostomy should be instituted in patients with severe TBI with the aim of improving their clinical outcomes.</p>","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":"51 3","pages":"350-356"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12831543/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146055627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: We present a modification of the Blumgart and Kakita techniques, which we call GaMBK (Gamboa-Modified Blumgart and Kakita) anastomosis. Our primary objective was to evaluate the association between clinically relevant postoperative pancreatic fistula (POPF, grades B/C) and the type of pancreaticojejunal anastomosis performed during pancreaticoduodenectomy (GaMBK vs Blumgart).
Methods: From June 2021 to June 2022, the Blumgart anastomosis was performed, and from July 2022 to March 2024, the GaMBK technique was implemented. A total of 38 patients (15 men and 23 women) who underwent pancreaticoduodenectomy for malignant disease were included in this historical cohort study.
Results: The median pancreatic duct diameter was 3mm in both the GaMBK and Blumgart groups (p=0.79). Median drain amylase levels were 38 U/L (range 30-1200) in the GaMBK group and 34U/L (range 30-3263) in the Blumgart group (p=0.40). Clinically relevant POPF occurred in 8.7% of the GaMBK group and 6.7% of the Blumgart group (p=1). All cases were grade B, and no grade C fistulas were identified. Median hospital stay was 7 days for the GaMBK group and 6 days for the Blumgart group. No association was found between the GaMBK technique and an increased risk of POPF (RR 1.304; 95% CI: 0.129-13.149; p=0.66).
Conclusion: The GaMBK anastomosis is a technically simpler modification of the Blumgart and Kakita techniques that does not increase the risk of clinically relevant POPF.
介绍:我们提出了一种改进的Blumgart和Kakita技术,我们称之为GaMBK (Gamboa-Modified Blumgart and Kakita)吻合。我们的主要目的是评估临床相关的术后胰瘘(POPF,分级B/C)与胰十二指肠切除术中胰空肠吻合类型之间的关系(GaMBK vs Blumgart)。方法:2021年6月~ 2022年6月行Blumgart吻合,2022年7月~ 2024年3月行GaMBK吻合。这项历史队列研究共纳入38例因恶性疾病行胰十二指肠切除术的患者(15名男性和23名女性)。结果:GaMBK组和Blumgart组的胰管中位直径均为3mm (p=0.79)。GaMBK组中位淀粉酶水平为38 U/L(范围30-1200),Blumgart组中位淀粉酶水平为34U/L(范围30-3263)(p=0.40)。GaMBK组和Blumgart组的临床相关POPF发生率分别为8.7%和6.7% (p=1)。所有病例均为B级,未发现C级瘘。GaMBK组的中位住院时间为7天,Blumgart组的中位住院时间为6天。GaMBK技术与POPF风险增加之间没有关联(RR 1.304; 95% CI: 0.129-13.149; p=0.66)。结论:GaMBK吻合术是Blumgart和Kakita技术的一种技术上更简单的改良,不会增加临床相关POPF的风险。
{"title":"The GaMBK Anastomosis: A Novel and Simplified Technique for Pancreaticojejunostomy.","authors":"Sergio Isidro Gamboa-Hoil, Ricardo Gamboa-Gutiérrez, Alejandro Medina-Campos","doi":"10.12865/CHSJ.51.03.12","DOIUrl":"10.12865/CHSJ.51.03.12","url":null,"abstract":"<p><strong>Introduction: </strong>We present a modification of the Blumgart and Kakita techniques, which we call GaMBK (Gamboa-Modified Blumgart and Kakita) anastomosis. Our primary objective was to evaluate the association between clinically relevant postoperative pancreatic fistula (POPF, grades B/C) and the type of pancreaticojejunal anastomosis performed during pancreaticoduodenectomy (GaMBK vs Blumgart).</p><p><strong>Methods: </strong>From June 2021 to June 2022, the Blumgart anastomosis was performed, and from July 2022 to March 2024, the GaMBK technique was implemented. A total of 38 patients (15 men and 23 women) who underwent pancreaticoduodenectomy for malignant disease were included in this historical cohort study.</p><p><strong>Results: </strong>The median pancreatic duct diameter was 3mm in both the GaMBK and Blumgart groups (p=0.79). Median drain amylase levels were 38 U/L (range 30-1200) in the GaMBK group and 34U/L (range 30-3263) in the Blumgart group (p=0.40). Clinically relevant POPF occurred in 8.7% of the GaMBK group and 6.7% of the Blumgart group (p=1). All cases were grade B, and no grade C fistulas were identified. Median hospital stay was 7 days for the GaMBK group and 6 days for the Blumgart group. No association was found between the GaMBK technique and an increased risk of POPF (RR 1.304; 95% CI: 0.129-13.149; p=0.66).</p><p><strong>Conclusion: </strong>The GaMBK anastomosis is a technically simpler modification of the Blumgart and Kakita techniques that does not increase the risk of clinically relevant POPF.</p>","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":"51 3","pages":"398-406"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12831546/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146047009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01Epub Date: 2025-09-30DOI: 10.12865/CHSJ.51.03.07
Gabriela Leață, Fabian Cezar Lupu, Ion Ciucă, Kamel Earar
The development of biodegradable biomaterials used in the medical industry represents a crucial aspect in the evolution of therapeutic medical techniques and methods. This research focuses on the microstructural characterization of alloys within the Mg-Ca-Sr system, which includes five distinct formulations composed primarily of magnesium with a fixed 0.5% calcium content and strontium varying from 0.5% to 3%. The alloys were cast in ceramic crucibles utilizing an induction furnace under an inert argon atmosphere to minimize oxidation and eliminate the flammability hazards inherent to magnesium-based materials. Microstructural evaluation was performed using both optical microscopy and scanning electron microscopy, demonstrating homogeneous microstructures free of porosity. The use of these types of biomaterials can foster new directions in implantation, both in orthopedics and maxillofacial medicine.
{"title":"Microstructural Study of Some Mg-Ca-Sr Based Alloys with Medical Applicability.","authors":"Gabriela Leață, Fabian Cezar Lupu, Ion Ciucă, Kamel Earar","doi":"10.12865/CHSJ.51.03.07","DOIUrl":"10.12865/CHSJ.51.03.07","url":null,"abstract":"<p><p>The development of biodegradable biomaterials used in the medical industry represents a crucial aspect in the evolution of therapeutic medical techniques and methods. This research focuses on the microstructural characterization of alloys within the Mg-Ca-Sr system, which includes five distinct formulations composed primarily of magnesium with a fixed 0.5% calcium content and strontium varying from 0.5% to 3%. The alloys were cast in ceramic crucibles utilizing an induction furnace under an inert argon atmosphere to minimize oxidation and eliminate the flammability hazards inherent to magnesium-based materials. Microstructural evaluation was performed using both optical microscopy and scanning electron microscopy, demonstrating homogeneous microstructures free of porosity. The use of these types of biomaterials can foster new directions in implantation, both in orthopedics and maxillofacial medicine.</p>","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":"51 3","pages":"357-366"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12831555/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146055604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01Epub Date: 2025-09-30DOI: 10.12865/CHSJ.51.03.04
Daniel Băluță, Mihaela Tănase, Andreea Mihaela Băluță, Anca Oana Dragomirescu, Ecaterina Ionescu
Various epidemiological indices have been developed to quantify oral hygiene and plaque accumulation, aiding clinical assessment and public health initiatives. The aim of this study was to highlight the main epidemiological indices used for standardized evaluation of oral hygiene and dental plaque, crucial for monitoring and control at both individual and population levels for preventive reason.
Material and method: Through a narrative review, the article analyzes the main indices used to assess oral hygiene.
Results: Some of the most clinically relevant indices are represented by the Oral Hygiene Index (OHI), Simplified Oral Hygiene Index (OHI-S), and Patient Hygiene Performance (PHP), which evaluate soft debris and calculus presence. Our research also covers several bacterial plaque indices including the Silness & Löe Plaque Index, Quigley-Hein Plaque Index, O'Leary Plaque Index, and Approximal Plaque Index (API), which measure plaque thickness and distribution.
Conclusions: The epidemiological indices presented serve as essential tools for dental practitioners and public health professionals to objectively assess oral hygiene status, guide personalized treatments, monitor progress and evaluate preventive programs.
{"title":"Epidemiological Indices for Assessing Oral Hygiene: A Relevant Tool in Public Health.","authors":"Daniel Băluță, Mihaela Tănase, Andreea Mihaela Băluță, Anca Oana Dragomirescu, Ecaterina Ionescu","doi":"10.12865/CHSJ.51.03.04","DOIUrl":"10.12865/CHSJ.51.03.04","url":null,"abstract":"<p><p>Various epidemiological indices have been developed to quantify oral hygiene and plaque accumulation, aiding clinical assessment and public health initiatives. The aim of this study was to highlight the main epidemiological indices used for standardized evaluation of oral hygiene and dental plaque, crucial for monitoring and control at both individual and population levels for preventive reason.</p><p><strong>Material and method: </strong>Through a narrative review, the article analyzes the main indices used to assess oral hygiene.</p><p><strong>Results: </strong>Some of the most clinically relevant indices are represented by the Oral Hygiene Index (OHI), Simplified Oral Hygiene Index (OHI-S), and Patient Hygiene Performance (PHP), which evaluate soft debris and calculus presence. Our research also covers several bacterial plaque indices including the Silness & Löe Plaque Index, Quigley-Hein Plaque Index, O'Leary Plaque Index, and Approximal Plaque Index (API), which measure plaque thickness and distribution.</p><p><strong>Conclusions: </strong>The epidemiological indices presented serve as essential tools for dental practitioners and public health professionals to objectively assess oral hygiene status, guide personalized treatments, monitor progress and evaluate preventive programs.</p>","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":"51 3","pages":"336-342"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12831552/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146055610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01Epub Date: 2025-09-30DOI: 10.12865/CHSJ.51.03.11
Antonio Andrusca, Cristina Maria Mihai, Cosmin Alexandru Pantazi, Simona Claudia Cambrea, Irina Ion, Emil Anton, Tatiana Chisnoiu, Ancuta Lupu, Mihaela Stoicescu, Florin Daniel Enache, Vasile Valeriu Lupu, Ileana Ion
Early differentiation between bacterial sepsis and viral infection in pediatric patients is critical for timely and appropriate therapy. We compared the inflammatory markers C-reactive protein (CRP), fibrinogen, erythrocyte sedimentation rate (ESR), and D-dimer in children with bacterial sepsis and those with SARS-CoV-2 infection to discern characteristic profiles.
Methods: We retrospectively analyzed 97 pediatric sepsis cases (culture-confirmed bacterial infections) and 100 pediatric COVID-19 cases (RT-PCR-confirmed SARS-CoV-2). The initial inflammatory marker levels were extracted from the medical records. Statistical comparisons of means and medians were performed, with significance set at p<0.05.
Results: CRP levels were markedly higher in bacterial sepsis (mean 8.1mg/dL, median 7.4mg/dL) than in COVID-19 (mean 4.1mg/dL, median 3.35mg/dL; p<0.001). ESR was also elevated in sepsis (mean 46mm/h) versus COVID-19 (mean 26mm/h; p<0.001). Fibrinogen showed the opposite pattern, being significantly lower in sepsis (mean 304.7mg/dL, median 267mg/dL) than in COVID-19 (mean 421mg/dL, median 448mg/dL; p<0.001). D-dimer was high in both groups; the COVID-19 cohort had a higher mean D-dimer (3.2μg/mL) with considerable variability, whereas the sepsis cohort's D-dimer was slightly lower and more homogeneous (difference not statistically significant).
Conclusions: Pediatric bacterial infection and COVID-19 exhibit distinct inflammatory marker profiles. Sepsis induces a more intense CRP and ESR response, whereas COVID-19 is characterized by markedly elevated fibrinogen and variable D-dimer levels.
{"title":"Inflammatory Markers in Pediatric Bacterial Sepsis vs. SARS-CoV-2 Infection: A Retrospective Study.","authors":"Antonio Andrusca, Cristina Maria Mihai, Cosmin Alexandru Pantazi, Simona Claudia Cambrea, Irina Ion, Emil Anton, Tatiana Chisnoiu, Ancuta Lupu, Mihaela Stoicescu, Florin Daniel Enache, Vasile Valeriu Lupu, Ileana Ion","doi":"10.12865/CHSJ.51.03.11","DOIUrl":"10.12865/CHSJ.51.03.11","url":null,"abstract":"<p><p>Early differentiation between bacterial sepsis and viral infection in pediatric patients is critical for timely and appropriate therapy. We compared the inflammatory markers C-reactive protein (CRP), fibrinogen, erythrocyte sedimentation rate (ESR), and D-dimer in children with bacterial sepsis and those with SARS-CoV-2 infection to discern characteristic profiles.</p><p><strong>Methods: </strong>We retrospectively analyzed 97 pediatric sepsis cases (culture-confirmed bacterial infections) and 100 pediatric COVID-19 cases (RT-PCR-confirmed SARS-CoV-2). The initial inflammatory marker levels were extracted from the medical records. Statistical comparisons of means and medians were performed, with significance set at p<0.05.</p><p><strong>Results: </strong>CRP levels were markedly higher in bacterial sepsis (mean 8.1mg/dL, median 7.4mg/dL) than in COVID-19 (mean 4.1mg/dL, median 3.35mg/dL; p<0.001). ESR was also elevated in sepsis (mean 46mm/h) versus COVID-19 (mean 26mm/h; p<0.001). Fibrinogen showed the opposite pattern, being significantly lower in sepsis (mean 304.7mg/dL, median 267mg/dL) than in COVID-19 (mean 421mg/dL, median 448mg/dL; p<0.001). D-dimer was high in both groups; the COVID-19 cohort had a higher mean D-dimer (3.2μg/mL) with considerable variability, whereas the sepsis cohort's D-dimer was slightly lower and more homogeneous (difference not statistically significant).</p><p><strong>Conclusions: </strong>Pediatric bacterial infection and COVID-19 exhibit distinct inflammatory marker profiles. Sepsis induces a more intense CRP and ESR response, whereas COVID-19 is characterized by markedly elevated fibrinogen and variable D-dimer levels.</p>","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":"51 3","pages":"390-397"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12831545/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146055634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: The review evaluates the impact of lifestyle interventions, including diet and exercise, on weight reduction to mitigate obesity's health risks and achieve sustainable weight loss in adults.
Methodology: A comprehensive literature search was conducted across three major databases: PubMed, Google Scholar, and institute Library e-Resources, resulting in the identification of 3018 relevant studies. After applying inclusion criteria, 42 trials were selected, with 15 meeting the criteria for meta-analysis. Utilizing rigorous statistical methods mean differences between intervention and control groups were calculated with a 95% confidence interval. Heterogeneity was assessed using the I2 statistic, and potential publication bias was evaluated through forest plots and funnel plots.
Results: The review encompassed a total of 2062 individuals, with an average age of 42.8±9.4 years. Our analysis revealed an overall effect size of -1.78 kg (-2.2%, -1.277%), indicative of significant weight reduction attributed to lifestyle interventions. Furthermore, our investigation unveiled variations in the effectiveness of interventions based on study duration and mode of delivery. Symmetric funnel plots suggested a low risk of publication bias, enhancing the credibility of our findings. This review underscores the importance of lifestyle treatments in weight management and highlights their accessibility and availability in recent years.
Conclusions: Our findings highlight the substantial impact of lifestyle interventions on weight reduction, demonstrating significant efficacy across diverse populations. The variations in effectiveness based on study duration and mode of delivery emphasize the need for tailored approaches in obesity management programs.
{"title":"Trimming the Scales: Unveiling the Impact of Lifestyle Interventions on Weight Reduction in Overweight and Obese Adults-A Comprehensive Systematic Review and Meta-Analysis.","authors":"Krishnasamy Vembu, Manjini Jayaram Kumari, Jayaseelan Venkatachalam, Shanmugam Ramesh","doi":"10.12865/CHSJ.51.03.02","DOIUrl":"10.12865/CHSJ.51.03.02","url":null,"abstract":"<p><strong>Background: </strong>The review evaluates the impact of lifestyle interventions, including diet and exercise, on weight reduction to mitigate obesity's health risks and achieve sustainable weight loss in adults.</p><p><strong>Methodology: </strong>A comprehensive literature search was conducted across three major databases: PubMed, Google Scholar, and institute Library e-Resources, resulting in the identification of 3018 relevant studies. After applying inclusion criteria, 42 trials were selected, with 15 meeting the criteria for meta-analysis. Utilizing rigorous statistical methods mean differences between intervention and control groups were calculated with a 95% confidence interval. Heterogeneity was assessed using the I2 statistic, and potential publication bias was evaluated through forest plots and funnel plots.</p><p><strong>Results: </strong>The review encompassed a total of 2062 individuals, with an average age of 42.8±9.4 years. Our analysis revealed an overall effect size of -1.78 kg (-2.2%, -1.277%), indicative of significant weight reduction attributed to lifestyle interventions. Furthermore, our investigation unveiled variations in the effectiveness of interventions based on study duration and mode of delivery. Symmetric funnel plots suggested a low risk of publication bias, enhancing the credibility of our findings. This review underscores the importance of lifestyle treatments in weight management and highlights their accessibility and availability in recent years.</p><p><strong>Conclusions: </strong>Our findings highlight the substantial impact of lifestyle interventions on weight reduction, demonstrating significant efficacy across diverse populations. The variations in effectiveness based on study duration and mode of delivery emphasize the need for tailored approaches in obesity management programs.</p>","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":"51 3","pages":"311-325"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12831554/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146055683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01Epub Date: 2025-09-30DOI: 10.12865/CHSJ.51.03.10
Monica Denisa Elena Popescu, Costel-Valentin Manda, Johny Neamțu, Andrei Biță, Adela Valeria Neamțu, Simona-Daniela Neamțu, Octavian Croitoru, Daniela Maria Calucică
Epirubicin, olaparib and ribociclib are three important anti-cancer agents representing distinct classes: an anthracycline (epirubicin), a PARP inhibitor (olaparib) and a CDK4/6 inhibitor (ribociclib). Analytical quantification of these drugs in biological fluids or in dosage forms often uses high-performance or ultra-performance liquid chromatography (HPLC or RP-HPLC), often coupled with ultraviolet (UV) or photo-diode-array detection (PDA), occasionally with mass spectrometric detection (MS). Within this paper, a rapid HPLC method with PDA detection for simultaneous quantitation of these analytes in pharmaceutical dosage forms is presented. The separation was carried out on a Vanquish Core (Thermo Scientific, USA) liquid chromatograph coupled with a PDA detector. Solid Phase Extraction (SPE) using Oasis PRiME HLB® cartridges was employed as sample preparation procedure. Chromatography was performed by using an unconventional porous graphitic carbon column (HypercarbTM); a gradient elution was carried out using a mixture of acetonitrile/tetrahydrofuran. The flow rate of the mobile phase and the injected volume were 1mL/min and 20μL, respectively. The column compartment temperature was set to 60°C. Each chromatographic peak was integrated at its maximum absorption wavelength. Quantification was performed with external standard method. All validation data were assessed according to European Medicines Agency (EMA) Guidelines, regarding stability, limit of detection/quantitation, precision, accuracy and linearity. The presented method was applied in pharmaceutical dosage forms analysis.
表柔比星、奥拉帕尼和核糖环尼是三种重要的抗癌药物,代表不同的类别:一种是蒽环类药物(表柔比星),一种是PARP抑制剂(奥拉帕尼),一种是CDK4/6抑制剂(核糖环尼)。生物液体或剂型中这些药物的分析定量通常使用高性能或超高性能液相色谱法(HPLC或RP-HPLC),通常与紫外线(UV)或光电二极管阵列检测(PDA)相结合,偶尔与质谱检测(MS)相结合。在本文中,提出了一种快速高效液相色谱与PDA检测同时定量的药物剂型中这些分析物的方法。采用Vanquish Core (Thermo Scientific, USA)液相色谱仪和PDA检测器进行分离。样品制备过程采用Oasis PRiME HLB®固相萃取(SPE)。采用非常规多孔石墨碳柱(HypercarbTM)进行色谱分析;用乙腈/四氢呋喃的混合物进行梯度洗脱。流动相流速为1mL/min,进样量为20μL。柱室温度设置为60℃。每个色谱峰在其最大吸收波长处进行积分。采用外标法定量。所有验证数据均根据欧洲药品管理局(EMA)指南进行评估,包括稳定性、检出限/定量、精密度、准确度和线性。该方法已应用于药物剂型分析。
{"title":"Fast HPLC Analysis of Three Antitumor Drugs in Pharmaceutical Dosages.","authors":"Monica Denisa Elena Popescu, Costel-Valentin Manda, Johny Neamțu, Andrei Biță, Adela Valeria Neamțu, Simona-Daniela Neamțu, Octavian Croitoru, Daniela Maria Calucică","doi":"10.12865/CHSJ.51.03.10","DOIUrl":"10.12865/CHSJ.51.03.10","url":null,"abstract":"<p><p>Epirubicin, olaparib and ribociclib are three important anti-cancer agents representing distinct classes: an anthracycline (epirubicin), a PARP inhibitor (olaparib) and a CDK4/6 inhibitor (ribociclib). Analytical quantification of these drugs in biological fluids or in dosage forms often uses high-performance or ultra-performance liquid chromatography (HPLC or RP-HPLC), often coupled with ultraviolet (UV) or photo-diode-array detection (PDA), occasionally with mass spectrometric detection (MS). Within this paper, a rapid HPLC method with PDA detection for simultaneous quantitation of these analytes in pharmaceutical dosage forms is presented. The separation was carried out on a Vanquish Core (Thermo Scientific, USA) liquid chromatograph coupled with a PDA detector. Solid Phase Extraction (SPE) using Oasis PRiME HLB® cartridges was employed as sample preparation procedure. Chromatography was performed by using an unconventional porous graphitic carbon column (HypercarbTM); a gradient elution was carried out using a mixture of acetonitrile/tetrahydrofuran. The flow rate of the mobile phase and the injected volume were 1mL/min and 20μL, respectively. The column compartment temperature was set to 60°C. Each chromatographic peak was integrated at its maximum absorption wavelength. Quantification was performed with external standard method. All validation data were assessed according to European Medicines Agency (EMA) Guidelines, regarding stability, limit of detection/quantitation, precision, accuracy and linearity. The presented method was applied in pharmaceutical dosage forms analysis.</p>","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":"51 3","pages":"383-389"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12831551/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146055601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}